Takeda, UK Bioventure GammaDelta Pair Up for Development of New Immunotherapies Based on T cells

Takeda Pharmaceutical said on May 10 that it has entered into a strategic partnership deal with UK-based biotech GammaDelta Therapeutics for the development of a novel T cell platform. The novel T cell platform being developed by the UK bioventure...read more